The Emerging Role of Digital Biomarkers in Cognitive Impairment

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
With digital health, we strive to improve patient outcomes by uncovering actionable insights. Digital biomarkers are consumer-generated physiological, environmental and behavioral measures collected through connected digital tools that can be used as an indicator to explain, influence and/or predict health-related outcomes.

Panelists will dive into the role of digital biomarkers and cognitive impairment, focusing on findings from a clinical feasibility study. Conducted by Lilly, Evidation Health and Apple, the study showed that an iPhone, Apple Watch, iPad, and the Beddit sleep monitoring device, in combination with digital apps, may have the potential to differentiate healthy people from people with cognitive impairment.
Speakers
photo
Vice President, Chief Digital Officer
Eli Lilly and Company
photo
Evidation Health, Co-Founder and President
Evidation Health
photo
Clinical Neuropsychologist; Assistant Professor
Brigham and Women's Hospital; Massachusetts General Hospital; Harvard Medical School
photo
Deputy Director, Innovation Technology Solutions
Gates Foundation